<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2216-0973</journal-id>
<journal-title><![CDATA[Revista Cuidarte]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cuid]]></abbrev-journal-title>
<issn>2216-0973</issn>
<publisher>
<publisher-name><![CDATA[Programa de Enfermería, Facultad de Ciencias de la Salud, Universidad de Santander UDES]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2216-09732022000100003</article-id>
<article-id pub-id-type="doi">10.15649/cuidarte.1219</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Validación Cuestionario FSI-10 y grado de satisfacción con dispositivos de inhaloterapia]]></article-title>
<article-title xml:lang="en"><![CDATA[Validation of the FSI-10 questionnaire and satisfaction assessment with inhaler devices]]></article-title>
<article-title xml:lang="pt"><![CDATA[Validação do questionário FSI-10 e satisfação com os dispositivos de inaloterapia]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rojas Laverde]]></surname>
<given-names><![CDATA[María-del-Pilar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Roa -Cubaque]]></surname>
<given-names><![CDATA[Marcela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Polanía Robayo]]></surname>
<given-names><![CDATA[Alba Yanira]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Corredor Gamba]]></surname>
<given-names><![CDATA[Sandra Patricia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Molina-Franky]]></surname>
<given-names><![CDATA[Jessica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Umbacía Salas]]></surname>
<given-names><![CDATA[Flor Ángela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Boyacá  ]]></institution>
<addr-line><![CDATA[Tunja ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Boyacá  ]]></institution>
<addr-line><![CDATA[Tunja ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Boyacá  ]]></institution>
<addr-line><![CDATA[Tunja ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de Boyacá  ]]></institution>
<addr-line><![CDATA[Tunja ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Universidad de Boyacá  ]]></institution>
<addr-line><![CDATA[Tunja ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Universidad de Boyacá  ]]></institution>
<addr-line><![CDATA[Tunja ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2022</year>
</pub-date>
<volume>13</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S2216-09732022000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S2216-09732022000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S2216-09732022000100003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: El tratamiento farmacológico de la EPOC se realiza progresiva y escalonadamente de acuerdo a la gravedad y puede ser modificado en función de la respuesta al mismo, por lo cual se han desarrollado instrumentos con el fin de evaluar la satisfacción del paciente con los distintos sistemas de inhalación; sin embargo, estos instrumentos han sido diseñados en su mayoría para pacientes con Asma.  Objetivo: Validar el instrumento FSI-10 y determinar el nivel de satisfacción de los dispositivos de inhaloterapia en pacientes con EPOC.  Materiales y métodos: Estudio transversal prospectivo y de validación de contenido, muestreo probabilístico estratificado con afijación proporcional; población de 337 pacientes con diagnóstico EPOC de la provincia Centro del departamento de Boyacá, Colombia. Se evaluó el cuestionario FSI-10 mediante la prueba de esfericidad de Bartlett, Kaiser-Meyer-Olkinyalfade Cronbach.  Resultados: Laprueba de esfericidad resultó estadísticamente significativa, sugiriendo la existencia de correlaciones dentro de la matriz de diez preguntas. La variación total explicable de las diez preguntas que corresponden a la versión del FSI 10 dio cuenta del 81 % de variabilidad. Los pacientes evaluados reportaron un nivel de satisfacción entre bastante a algo con los dispositivos de inhaloterapia.  Conclusiones: Las propiedades psicométricas permiten su utilización en la satisfacción del paciente con dispositivos de medicación inhalada, sin presentar diferencias en la comprensión y teniendo resultado fiables. La satisfacción con los dispositivos de inhaloterapia no es muy alta en la mayoría de la población evaluada.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: COPD pharmacological treatment is progressively staggered according to severity, which can be modified based on its response. Therefore, instruments have been developed to assess patient satisfaction with different inhaler devices. However, these instruments have been designed mostly for patients with asthma.  Objective: To validate the FSI-10 instrument and assess the degree of satisfaction with inhaler devices in COPD patients.  Materials and Methods: A prospective cross-sectional study for content validation and stratified probability sampling with proportional allocation was conducted with 337 COPD patients in the Central province of the department of Boyacá, Colombia. The FSI-10 questionnaire was assessed using Bartlett&#8217;s test of sphericity, Kaiser-Meyer-Olkin test and Cronbach&#8217;s alpha.  Results: The test of sphericity was statistically significant, suggesting the presence of a correlation within the ten-question test. Total explained variation of the FSI-10 questions accounted for 81% of the variation. Assessed patients reported a degree of satisfaction between fair to good with the use of inhaler devices.  Conclusions: FSI-10 psychometric properties enable its use in assessing patient satisfaction with inhaler devices with no difference in understanding and reliability results. Satisfaction with inhaler devices is not very high among the majority of the population assessed.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumen  Introdução: O tratamento farmacológico da DPOC é progressivo e escalonado de acordo com a gravidade e pode ser modificado de acordo com a resposta ao tratamento, por isso, foram desenvolvidos instrumentos para avaliar a satisfação do paciente com diferentes sistemas de inalação; no entanto, esses instrumentos foram elaborados principalmente para pacientes com asma.  Objetivo:  Validar o instrumento FSI-10 e determinar o nível de satisfação com os dispositivos de inaloterapia em pacientes com DPOC.  Materiais e métodos:  Estudo transversal prospectivo e de validação de conteúdo, amostragem probabilística estratificada com alocação proporcional; população de 337 pacientes diagnosticados com DPOC na província central do departamento de Boyacá, Colômbia. O questionário FSI-10 foi avaliado usando o teste de esfericidade de Bartlett, Kaiser-Meyer-Olkin e o alfa de Cronbach.  Resultados:  O teste de esfericidade foi estatisticamente significativo, sugerindo a existência de correlações dentro da matriz de dez perguntas. A variação total explicável das dez perguntas correspondentes à versão FSI 10 foi responsável por 81 % da variabilidade. Os pacientes avaliados relataram um nível de satisfação entre bastante e moderada com os dispositivos de inaloterapia.  Conclusões:  As propriedades psicométricas permitem seu uso na satisfação do paciente com dispositivos de medicamentos inalados, sem diferenças na compreensão e resultados confiáveis. A satisfação com os dispositivos de inaloterapia não é muito alta na maioria da população avaliada.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Validez de las Pruebas]]></kwd>
<kwd lng="es"><![CDATA[Reproducibilidad de Resultados]]></kwd>
<kwd lng="es"><![CDATA[Enfermedad pulmonar]]></kwd>
<kwd lng="en"><![CDATA[Validity of Tests]]></kwd>
<kwd lng="en"><![CDATA[Reproducibility of Results]]></kwd>
<kwd lng="en"><![CDATA[Lung Diseases]]></kwd>
<kwd lng="pt"><![CDATA[Validade do Teste]]></kwd>
<kwd lng="pt"><![CDATA[Reprodutibilidade dos Resultados]]></kwd>
<kwd lng="pt"><![CDATA[Doença Pulmonar.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>Asociación Latinoamericana de Tórax (ALAT)</collab>
<source><![CDATA[Recomendaciones para el diagnóstico y tratamiento de la Enfermedad Pulmonar Obstructiva Crónica (EPOC)]]></source>
<year>2011</year>
<edition>1</edition>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>Global Initiative for Chronic Obstructive Lung Disease</collab>
<source><![CDATA[Global strategy for diagnosis, management, and prevention of COPD Disease 2018]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Enfermedades no trasmisibles. Nota Descriptiva]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<article-title xml:lang=""><![CDATA[Prevención y control de las enfermedades no transmisibles: aplicación de la estrategia mundial]]></article-title>
<source><![CDATA[En: 61ª Asamblea Mundial de la Salud. Resolución A61/8 18 de abril de 2008]]></source>
<year>2008</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Halbert]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Natoli]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Gano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Badamgarav]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Buist]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Mannnino]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global burden of COPD: systematic review and meta-analysis]]></article-title>
<source><![CDATA[European Respiratory Journal]]></source>
<year>2006</year>
<volume>28</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>523-32</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menezes]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Perez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Jardim]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Muiño]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lopez]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Valdivia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2005</year>
<page-range>366 9500: 1875-81</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caballero]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Jaramillo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bolivar]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Sanabria]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Osorio]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL Study)]]></article-title>
<source><![CDATA[Chest.]]></source>
<year>2008</year>
<volume>133</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>343-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<collab>Gobernación de Boyacá</collab>
<source><![CDATA[Indicadores básicos en salud. Boyacá 2011]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Roa]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Corredor]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Polanía]]></surname>
<given-names><![CDATA[AY]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento farmacológico y no farmacológico de la enfermedad pulmonar obstructiva crónica]]></article-title>
<source><![CDATA[Revista Investigación Salud Universidad Boyacá]]></source>
<year>2018</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>295-322</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zervas]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Samitas]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gaga]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study]]></article-title>
<source><![CDATA[International Journal of COPD]]></source>
<year>2016</year>
<volume>1</volume>
<page-range>1845-55</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Revicki]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient assessment of treatment satisfaction: methods and practical issues]]></article-title>
<source><![CDATA[Gut]]></source>
<year>2004</year>
<numero>53^sIV</numero>
<issue>53^sIV</issue>
<supplement>IV</supplement>
<page-range>40-4</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perpiñá]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Viejo]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Badia]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Cobos]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Picado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessment of Patient Satisfaction and Preferences With Inhalers in Asthma With the FSI-10 Questionnaire]]></article-title>
<source><![CDATA[Arch Bronconeumol.]]></source>
<year>2008</year>
<volume>44</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>346-52</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Puerta]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Carbonell]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Chamarro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis de las propiedades psicométricas de la versión en español del Internet Addiction Test]]></article-title>
<source><![CDATA[Revista Trastornos Adictivos]]></source>
<year>2012</year>
<volume>14</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>99-104</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paunonen]]></surname>
<given-names><![CDATA[SV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La fiabilidad de las mediciones agregadas: enseñanzas que se desprenden de la teoría psicométrica]]></article-title>
<source><![CDATA[Revista Investigación en personalidad]]></source>
<year>1984</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>383-94</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<collab>Global Initiative for Chronic Obstructive Lung Disease</collab>
<source><![CDATA[Global strategy for diagnosis, management, and prevention of COPD Updated 2017]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[VR]]></given-names>
</name>
<name>
<surname><![CDATA[Aguirre]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Arévalo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Casas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resultado de un programa de rehabilitación pulmonar sobre la adherencia y la técnica inhalatoria en pacientes con enfermedad respiratoria crónica]]></article-title>
<source><![CDATA[Rev Univ Ind Santander Salud.]]></source>
<year>2016</year>
<volume>48</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>508-15</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vestbo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hurd]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Agustí]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
<name>
<surname><![CDATA[Vogelmeier]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Anzueto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estrategia global para el diagnóstico, manejo y prevención de la enfermedad pulmonar obstructiva crónica: resumen ejecutivo de GOLD]]></article-title>
<source><![CDATA[Revista estadounidense de medicina respiratoria y de cuidados críticos]]></source>
<year>2012</year>
<volume>187</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>347-65</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<collab>Ont Health Technol Assess Ser</collab>
<article-title xml:lang=""><![CDATA[Chronic obstructive pulmonary disease (COPD) evidentiary framework]]></article-title>
<source><![CDATA[Ont Health Technol Assess Ser]]></source>
<year>2012</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1-97</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Polatli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bilgin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Saylan]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Baslilar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Toprak]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ergen]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A cross sectional observational study on the influence of chronic obstructive pulmonary disease on activities of daily living: the COPD-Life study]]></article-title>
<source><![CDATA[Tuberk Toraks]]></source>
<year>2012</year>
<volume>60</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-12</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lujan]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Cardona]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Construcción y validación de escalas de medición en salud: revisión de propiedades psicométricas]]></article-title>
<source><![CDATA[Revista Archivos de Medicina]]></source>
<year>2015</year>
<volume>11</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<collab>Organización Mundial de la Salud</collab>
<article-title xml:lang=""><![CDATA[¿Qué calidad de vida? Grupo de la Organización Mundial de la Salud sobre la calidad de vida. Foro Mundial de la Salud]]></article-title>
<source><![CDATA[Rev Inter Desar Sanit.]]></source>
<year>1996</year>
<volume>17</volume>
<page-range>385-7</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conceptos básicos sobre la validación de escalas]]></article-title>
<source><![CDATA[Rev. Col. Psiquiatría.]]></source>
<year>1998</year>
<volume>27</volume>
<page-range>121-30</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Echeverry]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validating scales used for measuring factors in medicine]]></article-title>
<source><![CDATA[Rev Salud Pública.]]></source>
<year>2004</year>
<volume>6</volume>
<page-range>302-18</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carvajal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Centeno]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Watson]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rubiales]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How is an instrument for measuring health to be validated?]]></article-title>
<source><![CDATA[An Sist Sanit Navar]]></source>
<year>2011</year>
<volume>34</volume>
<page-range>63-72</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perpiñá]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Viejo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchis]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Badia]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Cobos]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Picado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación de la satisfacción del paciente y preferencias con inhaladores en asma con el cuestionario FSI-10]]></article-title>
<source><![CDATA[Revista Archivos de Bronconeumología]]></source>
<year>2008</year>
<volume>44</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>346-52</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Kiebert]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Partridge]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development of the Satisfaction with Inhaled Asthma Treatment Questionnaire]]></article-title>
<source><![CDATA[Eur Respir J.]]></source>
<year>2003</year>
<volume>2</volume>
<page-range>127-34</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schurmann]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Schmidtmann]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Moroni]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Massey]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Qidan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Respimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction]]></article-title>
<source><![CDATA[Treat Respir Med.]]></source>
<year>2005</year>
<page-range>53-61</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Serra]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Plaza]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Vadiola]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Morejón]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler]]></article-title>
<source><![CDATA[J Aerosol Med.]]></source>
<year>2002</year>
<page-range>59-64</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giner]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Torrejón]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Casán]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Granel]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Plaza]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preferencias de los pacientes en la elección de dispositivos de inhalación en polvo]]></article-title>
<source><![CDATA[Archivos de Bronconeumología]]></source>
<year>2004</year>
<page-range>106-9</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Villar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lizán]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Soto]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Peiró]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La satisfacción con el tratamiento]]></article-title>
<source><![CDATA[Revista Atención Primaria]]></source>
<year>2009</year>
<volume>41</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>637-45</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martín]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Barcina]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Marazuela]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio de validación de la versión adaptada al castellano del cuestionario de satisfacción con la medición inhalada en pacientes asmáticos (SATQ)]]></article-title>
<source><![CDATA[Revista Archivos de Bronconeumología]]></source>
<year>2006</year>
<volume>42</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>575-82</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ozturk]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kaya]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bilgin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación de la técnica del inhalador y la satisfacción del paciente con el inhalador de polvo seco de combinación fija de budesonida / formoterol en la enfermedad pulmonar obstructiva crónica (EPOC): datos sobre la práctica clínica de la vida real en Turquía]]></article-title>
<source><![CDATA[Tuberk Toraks]]></source>
<year>2012</year>
<volume>60</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>301-13</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Niño]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Barrera]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Satisfacción de uso de dispositivos de medicación inhalada en personas con enfermedad pulmonar en el servicio de medicina interna del Hospital San Rafael de Tunja - 2013 - 2014]]></article-title>
<source><![CDATA[Rev Médica de Risaralda]]></source>
<year>2015</year>
<volume>21</volume>
<page-range>1</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guyatt]]></surname>
<given-names><![CDATA[GH]]></given-names>
</name>
<name>
<surname><![CDATA[Feeny]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Patrick]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Measuring health-related quality of life]]></article-title>
<source><![CDATA[Ann Intern Med.]]></source>
<year>1993</year>
<page-range>622-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
